Why has Kenvue's Tylenol sales volume dropped 15% in the past quarter compared to the same period last year?

Introduction

Tylenol's 15% sales volume drop in the past quarter compared to last year is a significant concern for Kenvue. This analysis will systematically identify, validate, and address the root cause while considering both immediate and long-term implications for the product and company.

I'll approach this issue by first clarifying key details, ruling out external factors, understanding the product and user journey, breaking down the metric, gathering relevant data, forming hypotheses, conducting root cause analysis, and finally proposing validation methods and next steps.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be seasonal factors at play. Has there been any significant change in illness patterns or weather conditions compared to last year?

Why it matters: Seasonal variations can greatly impact OTC medication sales. Expected answer: No significant changes in illness patterns or weather conditions. Impact on approach: If confirmed, we'll need to look deeper into product-specific or market-related factors.

• Considering potential market shifts, have there been any new competitor products or aggressive marketing campaigns in the pain relief category?

Why it matters: Competitive pressures could explain the sales volume drop. Expected answer: No major new competitors, but some increased marketing activity from existing brands. Impact on approach: If confirmed, we'll need to analyze our marketing strategy and product positioning.

• Thinking about internal changes, has there been any alteration to Tylenol's formulation, packaging, or pricing in the past year?

Why it matters: Product changes can significantly impact consumer behavior. Expected answer: No changes to formulation, minor packaging updates, slight price increase. Impact on approach: If confirmed, we'll need to investigate the impact of these changes on consumer perception and purchasing decisions.

• Considering distribution channels, have there been any changes in how or where Tylenol is being sold compared to last year?

Why it matters: Changes in availability or visibility can directly affect sales volume. Expected answer: Some reduction in shelf space in major retailers. Impact on approach: If confirmed, we'll need to analyze our distribution strategy and retailer relationships.

• Reflecting on brand perception, has there been any significant news or social media activity related to Tylenol or Kenvue in the past quarter?

Why it matters: Public perception can dramatically influence consumer behavior. Expected answer: No major news, but some negative social media discussions about pricing. Impact on approach: If confirmed, we'll need to investigate our brand management and communication strategies.